Cargando…

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

BACKGROUND: Human genetic factors influence the outcome of pegylated interferon and ribavirin hepatitis C therapy. We explored the role of IL28B, APOH and ITPA SNPs on the outcomes of triple therapy including telaprevir or boceprevir in patients with compensated cirrhosis chronically infected with H...

Descripción completa

Detalles Bibliográficos
Autores principales: About, Frédégonde, Oudot-Mellakh, Tiphaine, Niay, Jonathan, Rabiéga, Pascaline, Pedergnana, Vincent, Duffy, Darragh, Sultanik, Philippe, Cagnot, Carole, Carrat, Fabrice, Marcellin, Patrick, Zoulim, Fabien, Larrey, Dominique, Hézode, Christophe, Fontaine, Hélène, Bronowicki, Jean-Pierre, Pol, Stanislas, Albert, Matthew L., Theodorou, Ioannis, Cobat, Aurélie, Abel, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682920/
https://www.ncbi.nlm.nih.gov/pubmed/26670100
http://dx.doi.org/10.1371/journal.pone.0145105